Prolistem® at the ESHRE 40th – Amsterdam
We are proud to be a part of the exciting ESHRE 2024 conference, where new technologies and treatments are being…
Prolistem® is a fertility support solution that can significantly enhance the chances of sperm production for men with non-obstructive azoospermia (primary testicular failure). Prolistem® is patented and FDA-certified.
Prolistem® does it like rebooting your smartphone to fix glitches. Our six-month program has two steps: first, we create the perfect setting for sperm production by temporarily lowering testosterone. Then, in phase two, we bring testosterone back to normal, promoting robust and healthy sperm production. It’s like hitting a refresh button for your fertility journey!
The outcome of research about non-obstructive azoospermia,
Testosterone and Spermatogonial Stem Cell
Prolistem is the culmination of a lot of hard work, research, and thinking. Our main goal in all our research is to find solutions that can help other people. Thirty years ago, men with azoospermia had no options for having children. We studied, we searched, and finally, we found a way. Prolistem helps men with this problem make their families whole. It’s a new chance, a fresh start, a reason to smile.
We are proud to be a part of the exciting ESHRE 2024 conference, where new technologies and treatments are being…
The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia, a condition that can be incredibly…
We are proud to be a part of the exciting ESHRE 2023 conference, where new technologies and treatments are being…
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.